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Abstract
Prokaryotic type II CRISPR-Cas systems can be adapted to enable targeted genome modifications 
across a range of eukaryotes.1–7. Here we engineer this system to enable RNA-guided genome 
regulation in human cells by tethering transcriptional activation domains either directly to a 
nuclease-null Cas9 protein or to an aptamer-modified single guide RNA (sgRNA). Using this 
functionality we developed a novel transcriptional activation–based assay to determine the 
landscape of off-target binding of sgRNA:Cas9 complexes and compared it with the off-target 
activity of transcription activator–like (TAL) effector proteins8, 9. Our results reveal that 
specificity profiles are sgRNA dependent, and that sgRNA:Cas9 complexes and 18-mer TAL 
effector proteins can potentially tolerate 1–3 and 1–2 target mismatches, respectively. By 
engineering a requirement for cooperativity through offset nicking for genome editing or through 
multiple synergistic sgRNAs for robust transcriptional activation, we suggest methods to mitigate 
off-target phenomena. Our results expand the versatility of the sgRNA:Cas9 tool and highlight the 
critical need to engineer improved specificity.
Bacterial and archaeal CRISPR-Cas systems rely on short guide RNAs in complex with Cas 
proteins to direct degradation of complementary sequences present within invading foreign 
nucleic acids10–14. Recently the type II CRISPR-Cas system was engineered to effect robust 
RNA-guided genome modifications in multiple eukaryotic systems, significantly improving 
the ease of genome editing1–7. Here we expand the repertoire of sgRNA:Cas9-mediated 
control of eukaryotic genomes by developing sgRNA:Cas9 gene activators, thus enabling 
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RNA-guided eukaryotic genome regulation. We use this expanded toolset to gain insights 
into the specificity of targeting by the S. pyogenes type II CRISPR-Cas system in human 
cells, compare the specificity profiles to those of TALE-based transcriptional activators and 
suggest the use of offset nicking to generate double strand breaks (DSBs) as a potential route 
to improving sgRNA:Cas9 genome editing specificity.
In S. pyogenes, Cas9 generates a blunt-ended double-stranded break 3bp upstream of the 
protospacer-adjacent motif (PAM) via a process mediated by two catalytic domains in the 
protein: an HNH domain that cleaves the complementary strand of the DNA and a RuvC-
like domain that cleaves the non-complementary strand12. To enable RNA-guided genome 
regulation, it is essential to first eliminate Cas9 nuclease activity by ablating the natural 
activity of RuvC and HNH nucleases domains7. By searching for sequences with known 
structure that are homologous to Cas9 (refer Supplementary Note 1), we identified and 
mutated up to 4 amino acids likely involved in magnesium coordination (Supplementary 
Fig. 1a). The generated quadruple Cas9 mutant showed undetectable nuclease activity upon 
deep sequencing at the targeted loci (Supplementary Fig. 1b), implying that we had 
successfully reduced Cas9 nuclease activity to levels below the threshold of detection in our 
assay.
Nuclease-deficient Cas9 (hereafter referred to as Cas9N-) can in principle localize 
transcriptional regulatory domains to targeted loci by fusing these domains to either Cas9N- 
or to the sgRNA. We explored both approaches in parallel (Figs. 1a, 1b).
To generate a Cas9N- fusion protein capable of transcriptional activation, we directly fused 
the VP64 activation domain15 to the C terminus of Cas9N- (Fig. 1a). This Cas9N-VP64 
protein robustly activated transcription of reporter constructs when combined with sgRNAs 
targeting sequences near the promoter, thereby displaying RNA-guided transcriptional 
activation (Figs. 1c, 1d, Supplementary Fig. 1c).
To generate sgRNA tethers capable of transcriptional regulation, we first determined which 
regions of the sgRNA will tolerate modifications by inserting random sequences into the 
sgRNA and assaying for sgRNA:Cas9 nuclease function. We found that sgRNAs bearing 
random sequence insertions at either the 5′ end of the crRNA portion or the 3′ end of the 
tracrRNA portion of a chimeric sgRNA retain functionality, whereas insertions into the 
tracrRNA scaffold portion of the chimeric sgRNA result in loss of function (Supplementary 
Fig. 2). To recruit VP64 to the sgRNA, we thus appended two copies of the MS2 
bacteriophage coat-protein binding RNA stem-loop16 to the 3′ end of the sgRNA (Fig. 1b) 
and expressed these chimeric sgRNAs together with Cas9N- and a MS2-VP64 fusion 
protein. We observed robust sequence-specific transcriptional activation from reporter 
constructs only in the presence of all 3 components (Figs. 1c, 1e).
Having successfully activated reporter construct transcription, we next attempted to regulate 
endogenous genes. We initially chose to target ZFP42 (REX1) and POU5F1 (OCT4), both 
tightly regulated genes involved in maintenance of pluripotency. For each gene we designed 
multiple sgRNAs targeting a ~5kb stretch of DNA upstream of the transcription start site 
and assayed transcriptional activation using either a promoter-luciferase reporter construct17 
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or directly via qPCR of the endogenous genes. We observed that introduction of individual 
sgRNAs modestly stimulated transcription of both target genes, but multiple sgRNAs acted 
synergistically to stimulate robust multi-fold transcriptional induction (Fig. 1f, 
Supplementary Figs. 3, 4, and Supplementary Table 1) 18, 19. In these experiments, both the 
Cas9 and sgRNA tethering approaches were observed to be effective, with the former 
displaying ~1.5–3 fold higher potency (Fig. 1f, Supplementary Fig. 3). This difference is 
likely due to the requirement for 2-component as opposed to 3-component complex 
assembly. However, the sgRNA tethering approach, in principle, enables different effector 
domains to be recruited by distinct sgRNAs so long as each sgRNA uses a different RNA-
protein interaction pair, enabling multiplex gene regulation using the same Cas9N- protein. 
We noted that a majority of the stimulation in the above experiments was by sgRNAs closer 
to the transcriptional start site, and thus correspondingly also attempted to regulate two 
additional genes, SOX2 and NANOG, via sgRNAs targeting within an upstream ~1kb 
stretch of promoter DNA (Supplementary Fig. 5). And indeed, this choice of sgRNAs 
proximal to the transcriptional start site resulted in robust gene activation.
The ability to both edit and regulate genes using the above RNA-guided system opens the 
door to versatile multiplex genetic and epigenetic regulation of human cells. However, an 
increasingly recognized constraint on Cas9-mediated engineering is the apparently limited 
specificity of sgRNA:Cas9 targeting20. Resolution of this issue requires in-depth 
interrogation of Cas9 affinity for a very large space of target sequence variations. Towards 
this we adapted our RNA-guided transcriptional activation system to serve this purpose. Our 
approach provides a direct high-throughput readout of Cas9-targeting in human cells, avoids 
complications introduced by dsDNA cut toxicity and mutagenic repair incurred by 
specificity testing with native nuclease-active Cas9 and can be adapted to any programmable 
DNA binding system. To illustrate this latter point, we also applied this system to evaluate 
TALE specificity. The methodology of our approach is outlined in Fig. 2a (also see 
Supplementary Fig. 6): Briefly, we design a construct library in which each element of the 
library comprises a minimal promoter driving a dTomato fluorescent protein. Downstream 
of the transcription start site a 24bp (A/C/G) random transcript tag is inserted and two TF 
binding sites are placed upstream of the promoter: one is a constant DNA sequence shared 
by all library elements. The second is a variable feature that bears a ‘biased’ library of 
binding sites which are engineered to span a large collection of sequences that present many 
combinations of mutations of target sequence that the programmable DNA targeting 
complex was designed to bind. We achieved this using degenerate oligonucleotides 
engineered to have nucleotide frequencies at each position such that the target sequence 
nucleotide appears at a 79% frequency and each other nucleotide occurs at 7% frequency21. 
The reporter library is then sequenced to reveal the associations between the 24bp dTomato 
transcript tags and their corresponding ‘biased’ target site in the library element. The large 
diversity of the transcript tags assures that sharing of tags between different targets will be 
rare, whereas the biased construction of the target sequences means that sites with few 
mutations will be associated with more tags than sites with more mutations. Next we 
stimulate transcription of the dTomato reporter genes with either a control-TF engineered to 
bind the shared DNA site, or the target-TF that was engineered to bind the target site. As 
assayed by dTomato fluorescence, protein expression was observed to peak by ~48 hours. 
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To prevent over-stimulation of the library total RNA was harvested within 24 hours. We 
then measure the abundance of each expressed transcript tag in each sample by conducting 
RNAseq on the stimulated cells, and then map these back to their corresponding binding 
sites using the association table established earlier. Note that one would expect the control-
TF to excite all library members equally because its binding site is shared across all library 
elements, whereas the target-TF will skew the distribution of the expressed members to 
those that are preferentially targeted by it. This assumption is used to compute a final 
normalized expression level for each binding site by dividing the tag counts obtained for the 
target-TF by those obtained for the control-TF.
We used the above approach to first analyze the targeting landscape of multiple 
sgRNA:Cas9 complexes. Our data reveals that these complexes can potentially tolerate 1–3 
mutations in their target sequences (Fig. 2b). They are also largely insensitive to point 
mutations, except those localized to the PAM sequence (Fig. 2c). Introduction of 2 base 
mismatches significantly impairs activity, with highest sensitivity localized to the 8–10 
bases nearest to the 3′ end of the sgRNA target sequence (Figs. 2d). These results are further 
reaffirmed by specificity data generated using two different sgRNA:Cas9 complexes 
(Supplementary Fig. 7 and Supplementary Tables 2, 3). Notably, we found that different 
sgRNAs can have vastly different specificity profiles (Supplementary Figs. 7a, 7d), 
specifically, sgRNA2 here tolerates up to 3 mismatches and sgRNA3 only up to 1. Again the 
greatest sensitivity to mismatches was localized to the 3′ end of the spacer, albeit 
mismatches at other positions were also observed to affect activity.
We next conducted additional experiments to validate these results. Specifically, we first 
confirmed the assay is specific for the sgRNA being evaluated, as a corresponding mutant 
sgRNA is unable to stimulate the reporter library (Supplementary Fig. 8). We also 
confirmed via targeted experiments that single-base mismatches within 12bp of the 3′ end of 
the spacer in the assayed sgRNAs indeed still result in detectable targeting, however 2bp 
mismatches in this region result in significant loss of activity (Supplementary Fig. 9). 
Furthermore, based on the observed insensitivity to mutations in the 5′ portion of the spacer, 
we conjectured that this region was not entirely required for sgRNA specificity and thus 
likely small truncations in this region would still result in retention of sgRNA activity. 
Supporting this hypothesis we observed that 1–3bp 5′ truncations are indeed well tolerated 
(Supplementary Fig. 10). Finally, an interesting revelation of the single-base mismatch data 
from both these experiments was that the predicted PAM for the S. pyogenes Cas9 is not just 
NGG but also NAG20. We confirmed this result with targeted experiments using the wild-
type Cas9 in a nuclease assay (Supplementary Fig. 11).
Taken together, our data demonstrate that the sgRNA:Cas9 system can potentially tolerate 
multiple mismatches in its target sequence. Consequently, achieving high targeting 
specificity with current experimental formats will likely require judicious and potentially 
complicated bioinformatic choice of sgRNAs. Indeed, when we rescanned a previously 
generated set of ~190K Cas9 targets in human exons that had no alternate NGG targets 
sharing the last 13nt of the targeting sequence6 for the presence of alternate NAG sites or for 
NGG sites with a mismatch in the prior 13nt, only .04% were found to have no such 
alternate targets.
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We note that our theoretical calculations suggest that there should be an exponential 
relationship between the cutting and mutation rates induced by a Cas9 nuclease and the 
expression level of a gene driven by a Cas9-TF (refer Supplementary Note 2), such that 
direct tests of specificity using Cas9 nucleases should be more sensitive and also more 
reflective of consequences of the underlying chromatin context. However, our TF assay 
offers a significant compensatory advantage in the form of convenient high-throughput 
multiplexing via RNAseq.
We next applied our transcriptional specificity assay to examine the mutational tolerance of 
another widely used genome engineering tool, TALE proteins. As a genome editing tool 
usually TALE-FokI dimers are used, and for genome regulation TALE-VP64 fusions have 
been shown to be highly effective. We used the latter as it was compatible with our 
transcriptional activation assay and this format also reveals the specificity profile of 
individual TALE proteins. Examining the TALE off-targeting data (Figs. 2e, 2f, 2g) reveals 
that 18-mer TALEs22 can potentially tolerate 1–2 mutations in their target sequences, but 
fail to activate a large majority of 3 base mismatch variants in their targets. They are also 
particularly sensitive to mismatches nearer the 5′ end of their target sequences23. Notably, 
certain mutations in the middle of the target lead to higher TALE activity, an aspect that 
needs further evaluation. We confirmed a subset of the above results via targeted 
experiments in a nuclease assay (Supplementary Fig. 12). We also observed that shorter 
TALEs (14-mer and 10-mer) are progressively less tolerant to mismatches but also reduced 
in activity by an order of magnitude (Supplementary Fig. 13) 24. To decouple the role of 
individual repeat-variable diresidues (RVDs), we confirmed that choice of RVDs25 does 
contribute to base specificity but TALE specificity is also a function of the binding energy 
of the protein as a whole (Supplementary Fig. 14). While a larger data-set would shed 
further light into the intricacies of TALE specificity profiles, our data imply that engineering 
shorter TALEs or TALEs bearing a judicious composition of high and low affinity 
monomers can potentially yield higher specificity in genome engineering applications and 
the requirement for FokI dimerization in nuclease applications enables a further dramatic 
reduction in off-target effects especially when using the shorter TALEs26.
Unlike TALEs where direct control of the size or monomer composition is a ready approach 
to modulating specificity, there are limited current avenues for engineering the sgRNA:Cas9 
complex towards lower binding affinity (and hence higher specificity) for their targets27, 28. 
We therefore focused on exploiting cooperativity requirements to improve specificity, akin 
to the use of ZF/TALE fusions to the dimeric FokI endonuclease that creates the 
requirement for the simultaneous binding of two adjacent ZFs/TALEs. Because synergy 
between multiple complexes is critical to ensure robust target gene activation by 
Cas9N-VP64, transcriptional regulation applications of Cas9N- is naturally specific as 
individual off-target binding events should have minimal effect. Although it should be noted 
that since individual sgRNA:Cas9 complexes can result in measurable activation (Fig. 1f), 
potential off-target effects might be magnified when perturbations are highly multiplexed.
In the context of genome-editing, we chose to focus on creating off-set nicks to generate 
DSBs. Our motivation stems from the observation (Supplementary Fig. 15) that a large 
majority of nicks do not result in non-homologous end joining (NHEJ) mediated indels29., 
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and thus when inducing off-set nicks, off-target single nick events will likely result in very 
low indel rates. Towards this we found that inducing off-set nicks to generate DSBs is 
highly effective at inducing gene disruption at both integrated reporter loci (Fig. 3) and at 
the native AAVS1 genomic locus (Supplementary Figs. 16, 17). Furthermore, we also noted 
that consistent with the standard model for homologous recombination (HR) mediated 
repair30 engineering of 5′ overhangs via off-set nicks generated more robust NHEJ events 
than 3′ overhangs (Fig. 3b). In addition to a stimulation of NHEJ, we also observed robust 
induction of HR when the 5′ overhangs were created. generation of 3′ overhangs did not 
result in improvement of HR rates (Figs. 3c). It remains to be determined if Cas9 
biochemistry or chromatin state and nucleotide composition of the genomic loci also 
contributed to the observed results above. While we did not actually measure off-target 
activity of this methodology, we believe the use of cooperativity such as with off-set nicks 
for generating DSBs offers a promising route for mitigating the effects of off-target 
sgRNA:Cas9 activity.
In summary, we have engineered the sgRNA:Cas9 system to enable RNA-guided genome 
regulation in human cells by tethering transcriptional activation domains to either a 
nuclease-null Cas9 or to guide RNAs. We expect the use of additional effector domains such 
as repressors, dimeric and monomeric nucleases, and epigenetic modulators to further 
expand this sgRNA:Cas9 toolset. As activation by individual sgRNA:Cas9 complexes was 
not observed to be strong and needed synergy among multiple complexes for robust 
transcription, exploring activity of Cas9-activators based on other Cas9 orthologs will be an 
important avenue for future studies.
Based on these RNA-guided regulators we additionally implemented a transcriptional 
activation based assay to determine the landscape of off-target binding by sgRNA:Cas9 
complexes and compared them to TALE effectors. We observed that the sgRNA:Cas9 
system can result in off-targeting events. We noted that there are large differences in 
specificity between evaluated sgRNAs (Supplementary Fig. 7). Based on this we speculate 
that sgRNA-DNA binding (and associated thermodynamic parameters) are a prominent 
determinant of specificity. Thus judicious choice of sgRNAs (such as avoidance of poly-G, 
poly-C rich spacers, and use of targets >3 mismatches away from the genome) will be a 
productive route to improved target specificity, albeit rules governing their precise design 
such as Tm, nucleotide composition, secondary structure of sgRNA spacer versus scaffold 
and role of the underlying chromatin structure of the target loci remain to be determined. 
Controlling the dose and duration of Cas9 and sgRNA expression will also be critical for 
engineering high specificity, and thus RNA based delivery will be an attractive genome 
editing route1. Although structure-guided design and directed evolution may eventually 
improve the specificity of individual Cas9 proteins, we have also shown here that 
engineering a requirement for cooperativity via off-set nicking to generate DSBs can 
potentially ameliorate off-target activity, and will perhaps be an useful approach for 
exploring therapeutic applications. Use of small molecule modulators of HR/NHEJ 
pathways and co-expression of associated end processing enzymes could further help refine 
this methodology. Overall, the ease and efficacy of editing and regulating genomes using the 
Cas9 RNA-guided genome engineering approach will have broad implications for our ability 
to tune and program complex biological systems.
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Online Methods
Plasmid construction
The Cas9 mutants were generated using the Quikchange kit (Agilent technologies). The 
target sgRNA expression constructs were either directly ordered as individual gBlocks from 
IDT and cloned into the pCR-BluntII-TOPO vector (Invitrogen); or assembled using Gibson 
assembly of oligonucleotides into a sgRNA-cloning vector (plasmid #41824). Appending of 
MS2 binding RNA-stem loop domains16 to the 3′ end of sgRNAs was via pcr primers. The 
vectors for the HR reporter assay involving a broken GFP were constructed by fusion PCR 
assembly of the GFP sequence bearing the stop codon and appropriate fragment assembled 
into the EGIP lentivector from Addgene (plasmid #26777) 6. These lentivectors were then 
used to establish the GFP reporter stable lines. TALENs used in this study were constructed 
using standard protocols22. Cas9N-6 and MS216 (plasmid #27121) fusions to VP64 and NLS 
domains were performed using standard pcr fusion protocol procedures. Both C-terminus 
and N-terminus NLS fusion constructs were made for each. The Cas9m4 nuclease-null 
mutant and fusions thereof (described in Supplementary Fig. 1) were used for all 
experiments. The promoter luciferase constructs for OCT4 and REX1 were obtained from 
Addgene (plasmid #17221 and plasmid #17222). The choice of TALEs and sgRNAs 1, 2 
and associated reagents was based on our earlier study targeting the AAVS1 locus6. sgRNA 
3 also based on our earlier study targets the DNMT3a locus6. Reporter libraries were 
constructed as per the design in Fig. 2a, and involved Gibson assembly of PCR fragments 
generated using degenerate oligonucleotides from IDT. DNA reagents developed in this 
study will be made available via Addgene (http://www.addgene.org/crispr/church/).
Cell culture and transfections
HEK 293T cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM, 
Invitrogen) high glucose supplemented with 10% fetal bovine serum (FBS, Invitrogen), 
penicillin/streptomycin (pen/strep, Invitrogen), and non-essential amino acids (NEAA, 
Invitrogen). Cells were maintained at 37°C and 5% CO2 in a humidified incubator.
Transfections involving nuclease assays were as follows: 0.4×106 cells were transfected 
with 2μg Cas9 plasmid, 2μg sgRNA and/or 2μg DNA donor plasmid using Lipofectamine 
2000 as per the manufacturer’s protocols. Cells were harvested 3 days after transfection and 
either analyzed by FACS, or for direct assay of genomic cuts the genomic DNA of ~1 × 106 
cells was extracted using DNAeasy kit (Qiagen). For these PCR was conducted to amplify 
the targeting region with genomic DNA derived from the cells and amplicons were deep 
sequenced by MiSeq Personal Sequencer (Illumina) with coverage >200,000 reads. The 
sequencing data was analyzed to estimate NHEJ efficiencies.
For transfections involving transcriptional activation assays: 0.4×106 cells were transfected 
with (1) 2μg Cas9N-VP64 plasmid, 2μg sgRNA and/or 0.25μg of reporter construct; or (2) 
2μg Cas9N- plasmid, 2μg MS2-VP64, 2μg sgRNA-2XMS2aptamer and/or 0.25μg of reporter 
construct. Cells were harvested 24–48hrs post transfection and assayed using FACS or 
immunofluorescence methods, or their total RNA was extracted and these were 
subsequently analyzed by RT-PCR. Here standard taqman probes from Invitrogen for 
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REX1, OCT4, SOX2 and NANOG were used, with normalization for each sample 
performed against GAPDH.
For transfections involving transcriptional activation assays for specificity profile of 
sgRNA:Cas9 complexes and TALEs: 0.4×106 cells were transfected with (1) 2μg 
Cas9N-VP64 plasmid, 2μg sgRNA and 0.25μg of reporter library; or (2) 2μg TALE-TF 
plasmid and 0.25μg of reporter library; or (3) 2μg control-TF plasmid and 0.25μg of reporter 
library. Cells were harvested 24hrs post transfection (to avoid the stimulation of reporters 
being in saturation mode). Total RNA extraction was performed using RNAeasy-plus kit 
(Qiagen), and standard RT-pcr performed using Superscript-III (Invitrogen). Libraries for 
next-generation sequencing were generated by targeted pcr amplification of the transcript-
tags.
Computational and sequence analysis for calculation of Cas9-TF and TALE-TF reporter 
expression levels
The high-level logic flow for this process is depicted in Supplementary Figure 6a, and 
additional details are given here. For details on construct library composition, see 
Supplementary Figures 6a (level 1) and 6b. Statistics are given in Supplementary Table 1.
Sequencing—For Cas9 experiments, construct library (Supplementary Figure 6a, level 3, 
left) and reporter gene cDNA sequences (Supplementary Figure 6a, level 3, right) were 
obtained as 150bp overlapping paired end reads on an Illumina MiSeq, whereas for TALE 
experiments, corresponding sequences were obtained as 51bp non-overlapping paired end 
reads on an Illumina HiSeq.
Construct library sequence processing—Alignment: For Cas9 experiments, 
novoalign V2.07.17 (http://www.novocraft.com/main/index.php) was used to align paired 
reads to a set of 250bp reference sequences that corresponded to 234bp of the constructs 
flanked by the pairs of 8bp library barcodes (see Supplementary Figure 6a, 3rd level, left). In 
the reference sequences supplied to novoalign, the 23bp degenerate Cas9 binding site 
regions and the 24bp degenerate transcript tag regions (see Supplementary Figure 6a, first 
level) were specified as Ns, wheras the construct library barcodes were explicitly provided. 
For TALE experiments, the same procedures were used except that the reference sequences 
were 203bp in length and the degenerate binding site regions were 18bp vs. 23bp in length. 
Validity checking: Novoalign output for comprised files in which left and right reads for 
each read pair were individually aligned to the reference sequences. Only read pairs that 
were both uniquely aligned to the reference sequence were subjected to additional validity 
conditions, and only read pairs that passed all of these conditions were retained. The validity 
conditions included: (i) Each of the two construct library barcodes must align in at least 4 
positions to a reference sequence barcode, and the two barcodes must to the barcode pair for 
the same construct library. (ii) All bases aligning to the N regions of the reference sequence 
must be called by novoalign as As, Cs, Gs or Ts. Note that for neither Cas9 nor TALE 
experiments did left and right reads overlap in a reference N region, so that the possibility of 
ambiguous novoalign calls of these N bases did not arise. (iii) Likewise, no novoalign-called 
inserts or deletions must appear in these regions. (iv) No Ts must appear in the transcript tag 
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region (as these random sequences were generated from As, Cs, and Gs only). Read pairs for 
which any one of these conditions were violated were collected in a rejected read pair file. 
These validity checks were implemented using custom perl scripts.
Induced sample reporter gene cDNA sequence processing—Alignment: SeqPrep 
(downloaded from https://github.com/jstjohn/SeqPrep on June 18, 2012) was first used to 
merge the overlapping read pairs to the 79bp common segment, after which novoalign 
(version above) was used to align these 79bp common segments as unpaired single reads to 
a set of reference sequences (see Supplementary Figure 6a, 3rd level, right) in which (as for 
the construct library sequencing) the 24bp degenerate transcript tag was specified as Ns 
whereas the sample barcodes were explicitly provided. Both TALE and Cas9 cDNA 
sequence regions corresponded to the same 63bp regions of cDNA flanked by pairs of 8bp 
sample barcode sequences. Validity checking: The same conditions were applied as for 
construct library sequencing (see above) except that: (a) Here, due prior SeqPrep merging of 
read pairs, validity processing did not have to filter for unique alignments of both reads in a 
read pair but only for unique alignments of the merged reads. (b) Only transcript tags 
appeared in the cDNA sequence reads, so that validity processing only applied these tag 
regions of the reference sequences and not also to a separate binding site region.
Assembly of table of binding sites vs. transcript tag associations—Custom perl 
was used to generate these tables from the validated construct library sequences 
(Supplementary Figure 6a, 4th level, left). Although the 24bp tag sequences composed of A, 
C, and G bases should be essentially unique across a construct library (probability of sharing 
= ~2.8e-11), early analysis of binding site vs. tag associations revealed that a non-negligible 
fraction of tag sequences were in fact shared by multiple binding sequences, likely mainly 
caused by a combination of sequence errors in the binding sequences, or oligo synthesis 
errors in the oligos used to generate the construct libraries. In addition to tag sharing, tags 
found associated with binding sites in validated read pairs might also be found in the 
construct library read pair reject file if it was not clear, due to barcode mismatches, which 
construct library they might be from. Finally, the tag sequences themselves might contain 
sequence errors. To deal with these sources of error, tags were categorized with three 
attributes: (i) safe vs. unsafe, where unsafe meant the tag could be found in the construct 
library rejected read pair file; shared vs. nonshared, where shared meant the tag was found 
associated with multiple binding site sequences, and 2+ vs. 1-only, where 2+ meant that the 
tag appeared at least twice among the validated construct library sequences and so presumed 
to be less likely to contain sequence errors. Combining these three criteria yielded 8 classes 
of tags associated with each binding site, the most secure (but least abundant) class 
comprising only safe, nonshared, 2+ tags; and the least secure (but most abundant) class 
comprising all tags regardless of safety, sharing, or number of occurrences.
Computation of normalized expression levels—Custom perl code was used to 
implement the steps indicated in Supplementary Figure 6a, levels 5–6. First, tag counts 
obtained for each induced sample were aggregated for each binding site, using the binding 
site vs. transcript tag table previously computed for the construct library (see Supplementary 
Figure 6c). For each sample, the aggregated tag counts for each binding site were then 
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divided by the aggregated tag counts for the positive control sample to generate normalized 
expression levels. Additional considerations relevant to these calculations included:
1. For each sample, a subset of “novel” tags were found among the validity-checked 
cDNA gene sequences that could not be found in the binding site vs. transcript tag 
association table. These tags were ignored in the subsequent calculations.
2. The aggregations of tag counts described above were performed for each of the 
eight classes of tags described above in binding site vs. transcript tag association 
table. Because the binding sites in the construct libraries were biased to generate 
sequences similar to a central sequence frequently, but sequences with increasing 
numbers of mismatches increasingly rarely, binding sites with few mismatches 
generally aggregated to large numbers of tags, wheras binding sites with more 
mismatches aggregated to smaller numbers. Thus, although use of the most secure 
tag class was generally desirable, evaluation of binding sites with two or more 
mismatches might be based on small numbers of tags per binding site, making the 
secure counts and ratios less statistically reliable even if the tags themselves were 
more reliable. Some compensation for this consideration obtains from the fact that 
the number of separate aggregated tag counts for n mismatching positions grew 
with the number of combinations of mismatching positions (equal to ), and so 
dramatically increases with n; thus the averages of aggregated tag counts for 
different numbers n of mismatches (shown in Figs. 2b, 2e, and in Supplementary 
Figs. 7, 8, 13, 14) are based on a statistically very large set of aggregated tag counts 
for n ≥ 2. We note that for consistency in this study, however, all tags were used for 
all data sets.
3. Finally, the binding site built into the TALE construct libraries was 18bp and tag 
associations were assigned based on these 18bp sequences, but some experiments 
were conducted with TALEs programmed to bind central 14bp or 10bp regions 
within the 18bp construct binding site regions. In computing expression levels for 
these TALEs, tags were aggregated to binding sites based on the corresponding 
regions of the 18bp binding sites in the association table, so that binding site 
mismatches outside of this region were ignored.
Expression level boxplot P-values—For the expression level boxplots in Fig. 2, and 
Supplementary Figs. 7, 8, 13, P-values were computed comparing the mean expression 
levels between consecutive numbers of target sequence mismatches, so that for a boxplot 
showing expression level values associated with the 9 mismatch values 0, 1, 2, …, 8, there 
are 8 comparisons (0 vs. 1, 1 vs. 2, 2 vs. 3, …, 7 vs. 8). Because the 0 mismatch expression 
level data comprises a single value, the t-test performed for the 0 vs. 1 comparison is a 
single sample t-test comparing this single value against the distribution of 1 mismatch 
expression levels. For all other comparisons, two-sample, two-tailed, t-tests were performed 
assuming unequal variance. All P-values were calculated using MatLab (MathWorks, 
Waltham) version 2013b. Significance is portrayed using symbols * for P<.05, ** for P<.
005, and *** for P<.0005, where all P values are Bonferroni-corrected for the number of 
comparisons presented in the boxplot. N.S. = Not Significant (P>=.05) (see Supplementary 
Table 3a).
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Statistical characterization of seed region—The normalized expression data for 
Cas9N VP64+sgRNA for target sequences with two mutations (see Fig. 2d) was analyzed to 
identify the seed region at the 3′ end of the 20bp target region (excluding the PAM sequence 
in positions 21–23) by considering a range of candidate seed start positions. For each 
candidate start position, the normalized expression levels for position pairs, both of which 
were at or beyond the candidate start position, were accumulated in one set, and the 
expression values for position pairs, at least one of which was ahead of the candidate start 
position were accumulated in another set. The P-value of the separation of the central values 
of these two sets of normalized expression levels was then computed using the Wilcoxon 
rank sum test as calculated by the MatLab ranksum function. The start position associated 
with the lowest P-value in the range of positions tested was interpreted as the beginning of 
the seed region. An adjacent start position had virtually the same P-value as the minimum 
(see Supplementary Table 3b).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. RNA-guided transcriptional activation
(a) To generate a Cas9N- fusion protein capable of transcriptional activation, we directly 
tethered the VP64 activation domain to the C terminus of Cas9N-. (b) To generate sgRNA 
tethers capable of recruiting activation domains, we appended two copies of the MS2 
bacteriophage coat-protein binding RNA stem-loop to the 3′ end of the sgRNA and 
expressed these chimeric sgRNAs together with Cas9N- and MS2-VP64 fusion protein. (c) 
Design of reporter constructs used to assay transcriptional activation is shown. Note that the 
two reporters bear distinct sgRNA target sites, and share a control TALE-TF target site. (d) 
Cas9N-VP64 fusions display RNA-guided transcriptional activation as assayed by both 
fluorescence-activated cell sorting (FACS) and immunofluorescence assays (IF). 
Specifically, whereas the control TALE-TF activated both reporters, the Cas9N-VP64 fusion 
activates reporters in a sgRNA sequence specific manner. (e) As assayed by both FACS and 
IF we observed robust sgRNA sequence-specific transcriptional activation from reporter 
constructs only in the presence of all 3 components: Cas9N-, MS2-VP64 and sgRNA bearing 
the appropriate MS2 aptamer binding sites. The bar in the micrographs is 100μm. (f) For the 
REX1 gene we designed 10 sgRNAs (positions indicated in the figure) targeting a ~5kb 
stretch of DNA upstream of the transcription start site (DNase hypersensitive sites are 
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highlighted in green), and assayed transcriptional activation using both the above 
approaches via qPCR of the endogenous genes. Although introduction of individual sgRNAs 
modestly stimulated transcription, multiple sgRNAs acted synergistically to stimulate robust 
multi-fold transcriptional induction. Note that in the absence of the 2X-MS2 aptamers on the 
sgRNA we do not observe transcriptional activation via the sgRNA-MS2-VP64 tethering 
approach. Data are means +/− SEM (N=3).
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Fig. 2. Evaluating the landscape of targeting by sgRNA:Cas9 complexes and TALEs
(a) The methodology of our approach is outlined (refer also Supplementary Fig. 6). (b) The 
targeting landscape of a sgRNA:Cas9 complex reveals that it is potentially tolerant to 1–3 
mutations in its target sequences. (c) The sgRNA:Cas9 complex is also largely insensitive to 
point mutations, except those localized to the PAM sequence. Notably this data reveals that 
the predicted PAM for the S. pyogenes Cas9 is not just NGG but also NAG. (d) Introduction 
of 2 base mismatches significantly impairs the sgRNA:Cas9 complex activity, primarily 
when these are localized to the 8–10 bases nearer the 3′ end of the sgRNA target sequence 
(in the heat plot the target sequence positions are labeled from 1–23 starting from the 5′ 
end). (e) Similarly examining the TALE off-targeting data for an 18-mer TALE reveals that 
it can potentially tolerate 1–2 mutations in its target sequence, and fails to activate a large 
majority of 3 base mismatch variants in its targets. (f) The 18-mer TALE is, similar to the 
sgRNA:Cas9 complexes, largely insensitive to single base mismatched in its target. (g) 
Introduction of 2 base mismatches significantly impairs the 18-mer TALE activity. Notably 
we observe that TALE activity is more sensitive to mismatches nearer the 5′ end of its target 
sequence (in the heat plot the target sequence positions are labeled from 1–18 starting from 
the 5′ end). Statistical significance symbols are: *** for P<.0005/n, ** for P<.005/n, * for 
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P<.05/n, and N.S. (Non-Significant) for P>= .05/n, where n is the number of comparisons 
(refer Supplementary Table 3).
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Fig. 3. Off-set nicking
(a) We employed the traffic light reporter29 to simultaneously assay for HR and NHEJ 
events upon introduction of targeted nicks or breaks: DNA cleavage events resolved through 
the HDR pathway restore the GFP sequence (via a donor template), whereas mutagenic 
NHEJ causes frame-shifts rendering the GFP out of frame and the downstream mCherry 
sequence in frame. For the assay, we designed 14 sgRNAs covering a 200bp stretch of 
DNA: 7 targeting the sense strand (U1–7) and 7 the antisense strand (D1–7). Using the 
Cas9D10A mutant, which nicks the complementary strand, we used different two-way 
combinations of the sgRNAs to induce a range of programmed 5′ or 3′ overhangs (the 
nicking sites for the 14 sgRNAs are indicated). (b) Inducing off-set nicks to generate DSBs 
is highly effective at inducing gene disruption. Notably off-set nicks leading to 5′ overhangs 
result in more NHEJ events as opposed to 3′ overhangs. (c) Again, off-set nicks leading to 5′ 
overhangs also result in more HR and NHEJ events as opposed to 3′ overhangs. In (b,c) the 
predicted overhang lengths are indicated below the corresponding x-axis legends. Data are 
means +/− SEM (N=3).
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